Clinical Trials Logo

Clinical Trial Summary

Randomized double blind placebo controlled pilot study/proof of concept-study to see if intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis suppurativa


Clinical Trial Description

Twenty patients with hidradenitis suppurativa will be enrolled and randomised to treatment with either botulinum toxin B or placebo (saline) in affected areas.

Intervention and recording of data will be performed every three months. After three months, all patients will receive active substance. After six months, randomization will revealed. Patients with clinical improvement will be given the opportunity to continue treatment for additional six months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03103074
Study type Interventional
Source University Hospital of North Norway
Contact
Status Active, not recruiting
Phase N/A
Start date June 1, 2017
Completion date September 23, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02904902 - Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Phase 3
Recruiting NCT03275870 - Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Phase 1/Phase 2
Active, not recruiting NCT03248531 - A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Phase 2
Completed NCT00329823 - Etanercept in Hidradenitis Suppurativa Phase 2
Terminated NCT03238469 - Microwave Ablation in Mild Axillary Hidradenitis Suppurativa N/A
Completed NCT01516749 - Anakinra as a Treatment for Hydradenitis Suppurativa Phase 2
Terminated NCT00722800 - A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS Phase 2
Completed NCT00395187 - A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa N/A
Recruiting NCT03553888 - Hidradenitis Suppurativa and Periodontal Diseases
Completed NCT01838499 - Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa Phase 2
Completed NCT01704534 - A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa Phase 2
Recruiting NCT01352078 - Wound Etiology and Healing Study N/A
Enrolling by invitation NCT03572738 - Hidradenitis Suppurativa Mail Survey
Recruiting NCT03054155 - Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser N/A
Completed NCT02833909 - Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients N/A
Recruiting NCT02163746 - Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing N/A
Recruiting NCT01818167 - An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa. N/A
Completed NCT01558375 - Anakinra in Hidradenitis Suppurativa Phase 2
Completed NCT02593604 - Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa N/A
Recruiting NCT03040804 - Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa N/A